Last 47 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 8.01 | 6.22 | 7.92 | 7.78 | 8.90 | 8.34 | 9.79 | 9.04 | 15.07 | 10.85 | 11.94 | 12.06 | 13.10 | 16.30 | 13.94 | 14.49 | 8.82 | 11.44 | 17.94 | 10.80 | 13.30 |
| — | -25.5% | -19.1% | -14.0% | -40.9% | -23.2% | -18.0% | -25.0% | +15.0% | -33.4% | -14.3% | -16.8% | +48.5% | +42.4% | -22.3% | +34.1% | -33.7% | +18.5% | +30.7% | +13.2% | +40.2% | |
| P/S Ratio | 0.65 | 0.48 | 0.61 | 0.78 | 0.74 | 0.69 | 0.76 | 0.73 | 0.98 | 0.80 | 0.81 | 0.71 | 0.61 | 0.79 | 0.66 | 0.73 | 0.48 | 0.56 | 0.84 | 0.79 | 0.92 |
| — | -30.1% | -18.9% | +7.1% | -24.9% | -14.5% | -6.9% | +3.7% | +60.2% | +2.0% | +24.1% | -3.8% | +27.2% | +39.6% | -21.7% | -7.0% | -47.4% | -42.5% | -11.9% | -17.3% | +17.1% | |
| P/B Ratio | 1.61 | 1.16 | 1.45 | 1.90 | 1.82 | 1.65 | 1.80 | 1.78 | 2.33 | 1.92 | 1.98 | 1.68 | 1.43 | 1.82 | 1.50 | 1.69 | 1.09 | 1.27 | 1.85 | 1.67 | 1.82 |
| — | -29.3% | -19.5% | +6.6% | -21.9% | -14.0% | -9.0% | +5.6% | +62.8% | +5.1% | +32.0% | -0.6% | +31.4% | +43.6% | -18.8% | +1.7% | -40.0% | -33.4% | +6.6% | -9.3% | +20.3% | |
| P/FCF | 13.19 | 10.33 | 14.96 | 11.97 | 24.95 | 10.40 | 25.63 | 7.29 | 45.85 | 7.17 | 16.63 | 10.62 | — | 14.33 | 18.62 | 19.03 | 27.26 | — | 11.23 | 23.02 | 10.34 |
| — | -0.7% | -41.6% | +64.1% | -45.6% | +45.0% | +54.2% | -31.3% | — | -49.9% | -10.7% | -44.2% | — | — | +65.8% | -17.3% | +163.6% | — | — | — | +160.2% | |
| EV / EBITDA | 6.34 | 5.13 | 6.09 | 7.14 | 6.75 | 6.38 | 7.20 | 6.81 | 9.65 | 7.46 | 8.35 | 8.23 | 8.32 | 9.60 | 8.48 | 9.33 | 6.84 | 8.21 | 10.35 | 8.26 | 8.60 |
| — | -19.6% | -15.4% | +4.8% | -30.0% | -14.5% | -13.7% | -17.3% | +16.0% | -22.3% | -1.5% | -11.7% | +21.6% | +16.9% | -18.1% | +12.9% | -20.5% | +15.8% | +20.9% | +22.9% | +36.8% | |
| EV / EBIT | 8.31 | 6.79 | 7.94 | 7.80 | 8.56 | 8.19 | 9.45 | 8.84 | 13.36 | 10.13 | 11.40 | 11.76 | 12.89 | 14.93 | 13.50 | 14.42 | 10.73 | 13.22 | 17.67 | 11.37 | 12.58 |
| — | -17.1% | -16.0% | -11.7% | -36.0% | -19.1% | -17.1% | -24.9% | +3.7% | -32.1% | -15.6% | -18.4% | +20.1% | +12.9% | -23.6% | +26.9% | -14.7% | +45.6% | +42.4% | +30.5% | +46.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 90.4% | 90.9% | 90.5% | 90.6% | 90.8% | 90.2% | 90.2% | 90.1% | 90.2% | 90.1% | 89.5% | 89.4% | 89.4% | 89.3% | 89.0% | 88.9% | 89.0% | 89.3% | 88.7% | 88.6% | 88.3% |
| — | +0.7% | +0.4% | +0.5% | +0.7% | +0.2% | +0.8% | +0.9% | +0.9% | +0.9% | +0.5% | +0.5% | +0.4% | -0.0% | +0.3% | +0.4% | +0.8% | -0.1% | +0.3% | -0.0% | -0.2% | |
| Operating Margin | 11.5% | 11.1% | 11.2% | 11.5% | 11.6% | 11.7% | 11.1% | 11.5% | 9.7% | 11.2% | 10.1% | 8.9% | 8.0% | 7.9% | 8.0% | 7.6% | 8.3% | 7.0% | 7.1% | 9.6% | 10.0% |
| — | -4.6% | +0.8% | +0.4% | +19.7% | +4.6% | +9.7% | +28.4% | +21.0% | +41.5% | +25.8% | +17.9% | -3.1% | +12.4% | +13.7% | -20.8% | -17.1% | -48.8% | -27.9% | -28.6% | -16.9% | |
| Net Margin | 8.6% | 7.7% | 7.8% | 9.9% | 8.3% | 8.2% | 7.7% | 8.1% | 6.5% | 7.4% | 6.8% | 5.8% | 4.7% | 4.8% | 4.7% | 5.1% | 5.5% | 4.9% | 4.7% | 7.3% | 6.9% |
| — | -6.3% | +0.4% | +23.0% | +27.1% | +11.4% | +13.4% | +38.3% | +39.3% | +53.3% | +44.8% | +15.2% | -14.4% | -2.1% | +0.8% | -30.4% | -20.7% | -51.4% | -32.6% | -26.9% | -16.4% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.0% | 4.7% | 4.6% | 6.1% | 5.2% | 5.0% | 4.6% | 4.9% | 3.9% | 4.5% | 4.2% | 3.5% | 2.7% | 2.8% | 2.7% | 2.9% | 3.1% | 2.8% | 2.5% | 3.8% | 3.4% |
| — | -6.7% | +0.1% | +22.7% | +32.2% | +12.0% | +10.9% | +40.6% | +43.2% | +59.9% | +54.3% | +19.4% | -11.8% | +1.8% | +7.4% | -22.5% | -8.2% | -43.9% | -21.2% | -23.2% | -17.4% | |
| ROA | 9.8% | 2.3% | 2.2% | 2.8% | 2.5% | 2.4% | 2.2% | 2.3% | 1.8% | 2.1% | 1.9% | 1.6% | 1.2% | 1.3% | 1.2% | 1.3% | 1.4% | 1.2% | 1.2% | 1.8% | 1.7% |
| — | -4.2% | +2.1% | +23.5% | +35.1% | +15.0% | +15.5% | +48.4% | +50.5% | +63.8% | +55.0% | +19.5% | -11.6% | +1.3% | +3.0% | -29.3% | -19.4% | -50.5% | -25.4% | -20.9% | -11.3% | |
| ROIC | 12.3% | 3.1% | 3.0% | 3.1% | 3.2% | 3.1% | 2.9% | 3.0% | 2.5% | 2.9% | 2.5% | 2.2% | 1.9% | 1.9% | 1.9% | 1.8% | 1.9% | 1.6% | 1.6% | 2.3% | 2.3% |
| — | -2.9% | +2.1% | +1.6% | +29.1% | +10.1% | +14.5% | +40.1% | +31.9% | +52.5% | +35.9% | +22.7% | -0.4% | +14.0% | +13.3% | -21.4% | -17.5% | -50.0% | -28.7% | -33.8% | -21.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.74 | 0.69 | 0.67 | 0.74 | 0.70 | 0.70 | 0.74 | 0.73 | 0.76 | 0.76 | 0.84 | 0.87 | 0.88 | 0.84 | 0.87 | 0.88 | 0.87 | 0.85 | 0.78 | 0.74 | 0.64 |
| — | -1.9% | -8.9% | +1.4% | -8.3% | -8.0% | -12.0% | -15.3% | -13.3% | -9.7% | -3.4% | -2.0% | +0.7% | -0.8% | +11.2% | +20.0% | +37.1% | +43.1% | +31.2% | +12.4% | -2.2% | |
| Debt / EBITDA | 2.11 | 7.69 | 7.79 | 8.09 | 7.55 | 7.68 | 8.45 | 8.00 | 9.57 | 8.56 | 10.02 | 11.26 | 12.74 | 12.22 | 12.55 | 12.87 | 12.25 | 13.33 | 12.40 | 10.20 | 9.05 |
| — | +0.2% | -7.8% | +1.1% | -21.1% | -10.3% | -15.7% | -28.9% | -24.9% | -30.0% | -20.1% | -12.5% | +4.0% | -8.4% | +1.2% | +26.1% | +35.4% | +95.2% | +34.4% | +33.2% | +9.2% | |
| Current Ratio | 1.05 | 1.12 | 1.08 | 1.05 | 1.03 | 1.29 | 1.32 | 1.27 | 1.39 | 1.28 | 1.38 | 1.40 | 1.38 | 1.29 | 1.37 | 1.33 | 1.27 | 1.22 | 1.07 | 1.14 | 1.19 |
| — | -13.5% | -18.3% | -17.4% | -26.0% | +1.2% | -4.5% | -8.8% | +0.7% | -1.1% | +0.7% | +5.4% | +9.2% | +5.4% | +28.0% | +16.2% | +6.4% | +1.8% | -13.7% | -13.8% | +5.9% | |
| Quick Ratio | 0.98 | 1.04 | 1.01 | 0.98 | 0.96 | 1.19 | 1.23 | 1.17 | 1.28 | 1.17 | 1.28 | 1.29 | 1.28 | 1.18 | 1.26 | 1.21 | 1.15 | 1.12 | 0.98 | 1.04 | 1.09 |
| — | -12.5% | -17.7% | -16.5% | -25.3% | +1.8% | -4.2% | -8.9% | +0.6% | -0.9% | +1.7% | +6.4% | +10.5% | +5.9% | +28.9% | +16.8% | +6.2% | +1.4% | -15.7% | -16.8% | +2.8% | |
| Interest Coverage | 13.51 | 12.95 | 14.04 | 14.66 | 14.30 | 14.74 | 11.36 | 11.90 | 8.56 | 8.73 | 7.30 | 6.21 | 5.10 | 5.55 | 5.17 | 6.01 | 7.51 | 9.10 | 10.17 | 17.83 | 15.15 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying UHS stock.
Universal Health Services, Inc.'s current P/E is 8.0x. The average P/E over the last 4 quarters is 7.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Universal Health Services, Inc.'s current operating margin is 11.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Universal Health Services, Inc.'s business trajectory between earnings reports.